ClinicalTrials.Veeva

Menu

Comparison Between Diode Laser and Bleomycin in Treatment of Hemangioma

A

Assiut University

Status

Not yet enrolling

Conditions

Bleomycin Adverse Reaction

Treatments

Device: Diode laser

Study type

Observational

Funder types

Other

Identifiers

NCT06510829
Diode laser hemangioma

Details and patient eligibility

About

Assessment of the Effectiveness of Bleomycin Intralesional Injection and Diode Laser on Management of Infantile Hemangioma., with regard to :

  • Clinically based on Change in the Size and Color of Hemangioma.
  • Ultrasonography considering Vascularity ,Echogenicity , Height , and Morphology .
  • Comparison of Complications associated with Bleomycin and Diode Laser.

Enrollment

30 estimated patients

Sex

All

Ages

3 to 12 months old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age between 3 Months and 1 Year old.
  • Non Complicated Infantile Hemangioma

Exclusion criteria

  • Younger than 3 Months or older than 1 Year.
  • Complicated Infantile Hemangioma

Trial design

30 participants in 2 patient groups

Group A
Description:
Group will be treated with intralesional bleomycin injection
Group b
Description:
Group will be treated with application of diode laser
Treatment:
Device: Diode laser

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems